-
P2Y2 Signaling Enhances Microglial Aβ42 Clearance
2026-09-13
Kim et al. identified a nucleotide-dependent pathway in which fibrillar or oligomeric Aβ1–42 stimulates ATP release from microglia, activating P2Y2 receptors to promote migration, peptide uptake, and degradation. The study provides a mechanistic framework for interpreting how amyloid exposure can coordinate microglial recruitment with Aβ42 clearance while highlighting important limits for translation beyond primary mouse-cell models.
-
Lamotrigine (B2249) for Reliable Cell Assays
2026-09-12
A scenario-based guide to using Lamotrigine (SKU B2249) in viability, proliferation, cytotoxicity, and cardiomyocyte workflows. It connects formulation control, sodium-channel biology, orthogonal readouts, and supplier selection to improve interpretation and experimental reproducibility.
-
EdU Imaging Kits (Cy3) for S-Phase Assays
2026-09-11
EdU Imaging Kits (Cy3) convert active DNA replication into bright, quantifiable Cy3 fluorescence without the DNA denaturation required by BrdU assays. This guide connects a practical click-chemistry workflow with hepatocellular carcinoma research, lenvatinib-response studies, microscopy, and flow cytometry.
-
Adefovir Dipivoxil in Chronic Hepatitis B
2026-09-11
This reference review explains how adefovir dipivoxil combines oral prodrug delivery with selective inhibition of the HBV polymerase, supporting activity against both HBeAg-positive and HBeAg-negative chronic hepatitis B. Its synthesis of mechanistic, clinical, resistance, and safety evidence remains useful for designing hepatitis B virus research workflows and interpreting nucleotide analog antiviral data.
-
Kozak Libraries for Quantitative Transgene Expression
2026-09-10
Shukla and colleagues developed a pooled Kozak-sequence library that converts translation-initiation variants into a calibrated, approximately 100-fold range of transgene abundance. The study links this tunable expression framework to ACE2-mediated pseudovirus entry and to combined testing of expression and coding-sequence variants, providing a practical route for separating protein abundance effects from protein sequence effects.
-
Toremifene in Breast Cancer: 20 Years of Evidence
2026-09-10
This review synthesizes two decades of clinical and pharmacologic evidence for toremifene, emphasizing its role as a selective estrogen receptor modulator for postmenopausal patients with hormone-sensitive breast cancer. Its main practical contribution is a balanced comparison with tamoxifen and aromatase inhibitors, showing where distinct metabolism, tissue-selective estrogenic effects, and patient factors may inform endocrine-treatment selection.
-
Torin2: Selective mTOR Inhibitor for Cancer Research
2026-09-09
Torin2 is a potent, selective mTOR inhibitor with a reported EC50 of 0.25 nM and documented cellular selectivity over PI3K. It supports cancer research involving mTOR signaling, medullary thyroid carcinoma models, cell viability, migration, and combination treatment with cisplatin.
-
KX2-391 Dihydrochloride in Precision Screening
2026-09-09
KX2-391 dihydrochloride connects Src inhibition, tubulin disruption, HBV transcription suppression, and BoNT/A inhibition in one research tool. This guide translates those properties into phenotype-first screening workflows, assay controls, and practical troubleshooting for oncology, virology, and neurotoxin studies.
-
Baicalin Restores Visual Plasticity in Adult Amblyopia
2026-09-08
A 2026 NeuroImage study reports that Baicalin reactivated ocular dominance plasticity and restored visual performance in adult amblyopic mice. The work links this effect to reduced GABAergic inhibition and perineuronal-net expression in primary visual cortex, providing a mechanism-oriented framework for studying pharmacological reopening of adult cortical plasticity.
-
DHEA in PCOS Research: Model, Mechanism, and Assays
2026-09-08
Dehydroepiandrosterone (DHEA) is more than an ovarian steroid precursor: it is a powerful experimental perturbation for connecting steroidogenesis, mitochondrial cholesterol handling, and neural resilience. This guide translates recent PCOS evidence into better assay design while distinguishing disease modeling from therapeutic interpretation.
-
Cucurbitacin I: STAT3 Assay Workflows
2026-09-07
Cucurbitacin I, also known as JSI-124, supports mechanism-first studies that connect phospho-STAT3 suppression with DNA-binding, apoptosis, invasion, chemosensitivity, and xenograft outcomes. This guide combines practical oncology workflows with assay-design lessons from a human pacemaker assembloid study while clearly separating validated evidence from exploratory extensions.
-
EZ Cap EGFP mRNA 5-moUTP: Assay Design
2026-09-07
EZ Cap EGFP mRNA 5-moUTP is an enhanced green fluorescent protein mRNA designed for reproducible expression studies. This guide explains how to use its cap, 5-moU, and poly(A) architecture to distinguish delivery, translation, stability, and immune effects.
-
Ellagic Acid: CK2 Inhibition for Cancer Research
2026-09-05
Ellagic acid is a polyphenolic, ATP-competitive CK2 inhibitor used in cancer biology research, oxidative stress assay development, and apoptosis research. Its reported 40 nM CK2 IC50, limited aqueous solubility, and solid-state storage requirement make assay design and formulation controls essential.
-
Metronidazole Workflows for OAT3 and Microbiome
2026-09-04
Metronidazole is more than a nitroimidazole antibiotic: it supports controlled OAT3 inhibition, transporter-mediated drug interaction studies, and anaerobic microbiome perturbation. This practical guide connects those use cases with an allergic-rhinitis rat study while separating validated product data from exploratory workflow recommendations.
-
Obeticholic Acid for FXR Liver Fibrosis Studies
2026-09-04
Build receptor-proximal FXR experiments around bile acid transport, cholestasis, and fibrotic readouts with a practical workflow for Obeticholic Acid. The approach also shows how to distinguish FXR-driven effects from the cortisol–Notch–NK-cell mechanism reported in recent liver fibrosis research.